tiprankstipranks
AngioDynamics (ANGO)
NASDAQ:ANGO
US Market

AngioDynamics (ANGO) Earnings Dates, Call Summary & Reports

Compare
461 Followers

Earnings Data

Report Date
Jul 09, 2025
TBA Not Confirmed
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.12
Last Year’s EPS
-0.06
Same Quarter Last Year
Based on 3 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Apr 02, 2025
|
% Change Since: 1.66%
|
Next Earnings Date:Jul 09, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and profitability improvements, particularly in the MedTech and Mechanical Thrombectomy segments. The company increased its guidance for fiscal 2025, indicating confidence in future performance. However, there are ongoing challenges with NanoKnife reimbursement and minimal growth in the Med Device segment. Overall, the positive aspects significantly outweigh the lowlights.
Company Guidance
During the AngioDynamics Fiscal Year 2025 Third Quarter Earnings Call, the company increased its guidance for the year following strong performance. Total worldwide revenue was reported at $72 million, marking a 9% year-over-year increase. The MedTech segment grew by 22%, driven by platforms like Auryon, which saw a 17% increase, and the Mechanical Thrombectomy business, which grew by approximately 47%. The company's gross margin improved to 54%, up by 290 basis points compared to the previous year. Adjusted EBITDA turned positive at $1.3 million, contrasting with a $3.6 million loss in the same quarter of the previous fiscal year, and adjusted EPS was a loss of $0.08 per share, an improvement from the $0.16 loss per share recorded last year. AngioDynamics' updated guidance projects fiscal 2025 total revenue between $285 million and $288 million, with MedTech growth expected to be 14% to 16% and a gross margin range of 53% to 54%.
Strong Revenue Growth
Total worldwide revenue was $72 million, representing growth of over 9% year-over-year. MedTech segment grew 22%, and Auryon platform revenue increased by 17%.
Mechanical Thrombectomy Segment Success
Mechanical Thrombectomy products, AlphaVac and AngioVac, in combination grew approximately 47% over the second quarter of last year. AlphaVac revenue increased by over 160%.
Improving Profitability
Reported positive adjusted EBITDA of $1.3 million compared to a loss of $3.6 million in the prior year. Adjusted EPS loss improved from $0.16 to $0.08 per share.
Guidance Increase
Guidance increased for total revenue, MedTech growth, gross margin, adjusted EBITDA, and adjusted EPS for the fiscal year 2025.
---

AngioDynamics (ANGO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ANGO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 09, 20252025 (Q4)
-0.12 / -
-0.06
Apr 02, 20252025 (Q3)
-0.13 / -0.08
-0.1650.00% (+0.08)
Jan 08, 20252025 (Q2)
-0.11 / -0.04
-0.0520.00% (+0.01)
Oct 03, 20242025 (Q1)
-0.15 / -0.11
-0.128.33% (<+0.01)
Jul 16, 20242024 (Q4)
-0.17 / -0.06
0.02-400.00% (-0.08)
Apr 04, 20242024 (Q3)
-0.15 / -0.16
-0.03-433.33% (-0.13)
Jan 05, 20242024 (Q2)
-0.07 / -0.05
0.01-600.00% (-0.06)
Oct 04, 20232024 (Q1)
-0.13 / -0.12
-0.06-100.00% (-0.06)
Jul 12, 20232023 (Q4)
0.02 / 0.02
0.01100.00% (+0.01)
Mar 30, 20232023 (Q3)
>-0.01 / -0.03
0.03-200.00% (-0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

ANGO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 02, 2025$9.66$10.86+12.42%
Jan 08, 2025$9.40$12.94+37.66%
Oct 03, 2024$7.65$6.37-16.73%
Jul 16, 2024$5.93$7.51+26.64%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does AngioDynamics (ANGO) report earnings?
AngioDynamics (ANGO) is schdueled to report earning on Jul 09, 2025, TBA Not Confirmed.
    What is AngioDynamics (ANGO) earnings time?
    AngioDynamics (ANGO) earnings time is at Jul 09, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ANGO EPS forecast?
          ANGO EPS forecast for the fiscal quarter 2025 (Q4) is -0.12.
            ---

            AngioDynamics (ANGO) Earnings News

            Wider Q1 Loss Weighs on AngioDynamics (NASDAQ:ANGO) Stock
            Premium
            Market News
            Wider Q1 Loss Weighs on AngioDynamics (NASDAQ:ANGO) Stock
            2y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis